Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer-Reference-Cited by-同舟云学术

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer

Published:2021-12-08 Issue:3 Volume:13 Page:380-385
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Lee Su Yeon¹^ORCID,Kim Young Chul²^ORCID,Lee Kye Young³,Lee Sung Yong⁴^ORCID,Lee Shin Yup⁵^ORCID,Lee Min Ki⁶,Lee Jeong Eun⁷,Jang Seung Hun⁸,Jang Tae‐Won⁹,Choi Chang Min¹¹⁰^ORCID

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chonnam National University Hwasun Hospital Chonnam National University Medical School Hwasun South Korea

3. Department of Pulmonary Medicine Konkuk University School of Medicine Seoul South Korea

4. Division of Pulmonary, Allergy, and Critical Care Medicine Korea University College of Medicine Seoul South Korea

5. Department of Internal Medicine, School of Medicine Kyungpook National University Daegu South Korea

6. Department of Internal Medicine Pusan National University School of Medicine Busan South Korea

7. Department of Internal Medicine, Chungnam National University Hospital Chungnam National University School of Medicine Daejeon South Korea

8. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine Hallym University Sacred Heart Hospital Anyang South Korea

9. Department of Internal Medicine Kosin University Gospel Hospital Busan South Korea

10. Department of Oncology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14266

Reference26 articles.

1. Scientific Advances in Lung Cancer 2015

2. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

3. Non-small cell lung cancer targetable mutations: present and future

4. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. National Comprehensive Cancer Network.Non‐small cell lung cancer (Version 5. 2021).https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis;BMC Cancer;2024-07-15

2. The role of pharmacogenomics in personalized treatment of oncological diseases;Onkologiya. Zhurnal imeni P.A.Gertsena;2023